Healthtech firm Cera closes £500,000 from post-retirement living provider Auriens
Carers on Startups 100-featured digital homecare platform will receive training from experienced carer training provider Draycott Nursing & Care
Cera, the Startups 100-featured digital homecare provider, has landed £500,000 in funding from high-end ‘post-retirement’ living provider Auriens.
Founded by Dr Mahiben Maruthappu and Marek Sacha in 2015, London-based Cera is an on-demand care platform focused on dementia, Parkinson’s Disease, learning difficulties, cancer, and the elderly, that connects those in need of care with a carer based on their specific requirements.
The platform sends a list of appropriate, background-checked carers to choose from, who enter a digital record of each home visit, which can be sent on to family members and health practitioners.
This partnership will see any carers working through Cera’s platform receive training from Draycott Nursing & Care, the carer training provider owned by Auriens.
Cera has already formed relationships with a number of NHS clinical commissioning groups (CCGs) and hospitals in the capital and has plans to expand across the country and enhance its technological capabilities as it looks to shake up the UK care market.
The funding brings the company’s total investment up to nearly £3m after a £1.3m seed round in November 2016 and a further £1.4m seed funding in April this year.
Maruthappu commented: “This ground-breaking deal will see the best of care, technology and real estate come together to pioneer and lead the future of social care. At a time when pressures on the sector couldn’t be higher, it’s time that go-it-alone care providers form collaborative care partnerships, locally and across different parts of the country.”
See if you can get a Start Up Loan to help you start a business idea
(external site, opens in new tab)
Johnny Sandelson, co-founder of Auriens, said: “This investment is another important milestone for us. It demonstrates our commitment towards making sure technology plays a key role in the later-life market – a market we are determined to serve in an innovative and exciting way.”